Background The main purpose was to investigate the correlation between magnetic
resonance imaging (MRI)-based response patterns halfway through neoadjuvant …

Background Tailoring neoadjuvant chemotherapy (NAC) during breast cancer treatment is
performed to improve overall tumour response, with increasing evidence to support its role …

Purpose To evaluate the relevance of breast cancer subtypes for magnetic resonance
imaging (MRI) markers for monitoring of therapy response during neoadjuvant …

Purpose To evaluate which factors may influence magnetic resonance imaging (MRI)
performance in the detection of pathologic complete response (pCR) after neoadjuvant …

A pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is a signature
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …

Objective: To evaluate the usefulness of MR computer-aided detection (CAD) in patients
undergoing neoadjuvant chemotherapy for prediction of the pathological complete response …

Objectives This study aimed to investigate the predictability of breast MRI for pathologic
complete response (pCR) by molecular subtype in patients with breast cancer receiving …

Magnetic resonance imaging (MRI) has been proposed to have a role in predicting final
pathologic response when undertaken early during neoadjuvant chemotherapy (NAC) in …

Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …

Background Prior studies of the ability of magnetic resonance imaging (MRI) to predict
pathologic response to neoadjuvant chemotherapy have shown conflicting results that vary …